Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of pharmaceutical distributor Aceto Corporation (NASDAQ:ACET) jumped 21% today after reporting earnings.

So what: Net sales jumped 15.7%, to $129.3 million, and net income jumped 135.2% from a year ago to a record $11.3 million. On a per-share level, the company made $0.40, which was well above the $0.25 estimate from analysts. 

Now what: Pharmaceuticals continue to be a strong business for the company, with sales up 19%. The company's growth, along with the fact that it crushed earnings estimates, shows some real value in its shares, as well. Estimates for 2014 are for $1.03 per share before this beat, so at 11.5 times estimates, that will likely rise. I think there's value to be had. I also think that shares will continue to rise as profits improve, making today a buying opportunity despite the pop.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.